October 2024 ACIP Meeting Update: Influenza, COVID-19, RSV, and Other Vaccines.
Where this comes from
- Record sourced from PubMed, PMID 39849311.
- Also identified by DOI 10.1542/peds.2024-069926.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met October 23 to 24, 2024, to discuss influenza vaccines, chikungunya vaccines, COVID-19 vaccines, RSV (respiratory syncytial virus) immunizations, meningococcal vaccines, human papillomavirus vaccines, pneumococcal vaccines, and adult and child/adolescent immunization schedule revisions. This update summarizes the proceedings of these meetings, with an emphasis on topics that are most relevant to the pediatric population. Major updates for pediatric clinicians include information regarding COVID-19 and influenza vaccine recommendations, meningococcal vaccination considerations, and updates regarding the implementation and effectiveness of RSV immunization in pregnant people and infants.
Medical subject headings
- Influenza Vaccines
- COVID-19
- COVID-19 Vaccines
- Respiratory Syncytial Virus Vaccines
- Influenza, Human